Melanoma: all 3,073 studies
Page 1 of 31. Open to participants first (529), then studies with results posted, then the rest; newest registration first within each.
- Mirdametinib to Reduce the Size of Large/Giant Congenital Melanocytic Nevi in Children, Adolescents and Young AdultsNot yet recruitingNCT07891286Phase 2
- Using an Artificial Intelligence (AI) Tool for Melanoma DiagnosisRecruitingNCT07890415Phase 3
- Development and Multi-Centre Validation of a Novel Non-Invasive Melanoma Molecular Diagnostic TestRecruitingNCT07883954
- Neoadjuvant Pembrolizumab in Patients With High Risk, Stage IIB/IIC Cutaneous Melanoma: a Single Arm Proof of Concept Phase IIA Study.Not yet recruitingNCT07883759Phase 2
- Detection of the BRAF V600E Mutation in Liquid Biopsy Using the CRISPR/Cas12a SystemRecruitingNCT07870265Not applicable
- Trial Comparing CPDMA Versus Standard Breadloafing in WLE Specimens of Stage 1-II Cutaneous MelanomaNot yet recruitingNCT07869381Not applicable
- Dermatological Effects and Quality of Life in Oncology PatientsNot yet recruitingNCT07869186Not applicable
- Neoadjuvant RP2 + Nivolumab in Patients With MelanomaNot yet recruitingNCT07862530Phase 2
- Biomechanical Characterization of Skin Properties Using Impact Based-Analysis Method (IBAM)Not yet recruitingNCT07861022
- SI-B036-ST-101 in Advanced/Metastatic Solid TumorsNot yet recruitingNCT07857616Phase 1
- A Study of QL1706 Combined With OH2 Injection in Perioperative Treatment of Stage III Resectable Acral MelanomaNot yet recruitingNCT07854522Phase 4
- Clinical Investigator-Initiated Trial (IIT) of PD-L1-Targeted Radionuclide ProbesRecruitingNCT07848243Phase 2
- Cryoablation Combined With Hepatic Arterial Infusion of Iparomlimab and Tuvonralimab (QL1706), Intravenous Dacarbazine, and Oral Lenvatinib in Patients With Liver Metastases From Malignant Melanoma: a Single-arm, Phase II, Prospective TrialRecruitingNCT07847359Phase 2
- A Study of BL-M08D in Patients With Locally Advanced or Metastatic Melanoma and Other Solid TumorsNot yet recruitingNCT07841925Phase 1/2
- Adding Anakinra and Tocilizumab to Nivolumab and Ipilimumab for the Treatment of Melanoma Patients 50 Years of Age or OlderNot yet recruitingNCT07838974Phase 1
- Multiple Adjunct Therapies to Improve Immunotherapy Treatment in Patients With Locally Advanced or Metastatic Melanoma or Advanced Hepatocellular CancerNot yet recruitingNCT07836712Phase 2
- A Pilot Study of ctDNA-Guided Immune Checkpoint Inhibitor Duration in Patients With Advanced Melanoma.RecruitingNCT07830225Not applicable
- Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Randomized Controlled TrialNot yet recruitingNCT07820033Phase 2
- Phase 1b/2 Clinical Trial to Evaluate the Safety and Efficacy of Combination Therapy With Pembrolizumab and Irinotecan in Patients With Metastatic or Recurrent Malignant MelanomaNot yet recruitingNCT07817901Phase 1/2
- Gut Microbiome in Patients With Lung and Melanoma Cancer and Intestinal Microbiota in Gynecologic CancersNot yet recruitingNCT07815873Not applicable
- iSCIB1+ in Combination With Ipilimumab and Nivolumab as First-Line Treatment for Advanced Unresectable MelanomaNot yet recruitingNCT07815574Phase 3
- ENPP1/cGAS (EG) and FAP Expression Profiles in Solid Tumors: An Immunohistochemical Study in a Vietnamese CohortRecruitingNCT07808164
- Trial of Temozolomide in BAP1 Mutated Patients With Advanced or Metastatic Cutaneous MelanomaNot yet recruitingNCT07807878Phase 2
- Markers of Efficacy to Immunotherapy in Patients With Metastatic MelanomaNot yet recruitingNCT07794501
- Social Prescriptions and Micro-Learning to Improve Care for Cancer Patients and Their Support PersonsRecruitingNCT07788729Not applicable
- Exercise and Nutritional Intervention in Patients With Melanoma Receiving ImmunotherapyNot yet recruitingNCT07761871Not applicable
- 68Ga-SorB PET/CT Imaging in Patients With Solid TumorsRecruitingNCT07760012Not applicable
- Phase 1/2 Study of Intravenous Injection of STX-003 in Advanced Solid Tumors as Monotherapy or in Combination With PembrolizumabRecruitingNCT07751042Phase 1/2
- Tunlametinib in Combination With Pucotenlimab and Hydroxychloroquine in NRAS Mutant MelanomaRecruitingNCT07750067Phase 2
- A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid TumorsRecruitingNCT07749586Phase 1/2
- NeoAdjuvant, Spare-Adjuvant (NASA) in Stage IIIB-IV (M1a) MelanomaRecruitingNCT07740941Phase 2
- A Comparative Usability Study of Two Total Body Skin Imaging SystemsNot yet recruitingNCT07740642Not applicable
- Impact of Dysport on PMFF Donor ScarNot yet recruitingNCT07720726Phase 4
- Investigating the Combination of Bexmarilimab and Nivolumab in Solid Tumours, Melanoma and NSCLCRecruitingNCT07718243Phase 1/2
- Aggressive Lipid Lowering Therapy in ICI-Treated MelanomaRecruitingNCT07704918Not applicable
- PICSTAT Pilot Study for CD8 PET/CT-Guided Lifileucel Treatment in Advanced MelanomaNot yet recruitingNCT07700121Early Phase 1
- Timing of Immunotherapy in MelanomaRecruitingNCT07696715Not applicable
- Rituximab for Treatment of Checkpoint Inhibitor Induced Immune-related Adverse EventsRecruitingNCT07694414Phase 1
- MELanoma Brain Metastasis Treated With CYberknifeRecruitingNCT07691255
- A Multicenter Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.Not yet recruitingNCT07689812Not applicable
- Dietary Fiber to Induce Gut Microbiota-mediated Response to Immunotherapy in Melanoma.RecruitingNCT07686835Phase 2
- NEOSENT: Early Anti-PD-1 Therapy In High-Risk Stage II MelanomaRecruitingNCT07680699
- Clinical Study on High-fiber Diet and Short-term Fasting in Melanoma Under Immunotherapy With Checkpoint InhibitionRecruitingNCT07680452Not applicable
- Bright Light Therapy in Patients With Melanoma or Non-small Cell Lung Cancer (NSCLC) Who Are Receiving First-Line Immune Checkpoint BlockadeRecruitingNCT07661966Not applicable
- Feasibility of an Enhanced Symptom Monitoring and Expedited Subspecialty Care Referral Intervention to Improve Side Effect Management for Patients With Melanoma Receiving an Immune Checkpoint InhibitorNot yet recruitingNCT07660666Not applicable
- Evaluating a Decision Aid for Sentinel Lymph Node Biopsy in Intermediate-Risk MelanomaNot yet recruitingNCT07653087Not applicable
- A Phase II Trial of Tumour Infiltrating Lymphocyte Adoptive Cell Therapy in Patients With Immune Checkpoint Inhibitor Resistant Unresectable or Metastatic MelanomaNot yet recruitingNCT07651618Phase 2
- Gustabor Phase 2 - Treating Taste Changes During Cancer Therapy: A Randomized Study Evaluating an AI- Based Nutrition InterventionRecruitingNCT07649681Not applicable
- Pilot Study of Intermittent Fasting With Immune Checkpoint InhibitorsNot yet recruitingNCT07645742Not applicable
- Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced MelanomaRecruitingNCT07644897Phase 2
- Urinary Microbiome as a Biomarker for Melanoma Diagnosis and Response Prediction to Systemic Tumour TherapyRecruitingNCT07635732
- Circadian-Optimized Light Therapy for the Treatment of Patients With Advanced Melanoma Receiving Tumor-Infiltrating Lymphocyte TherapyNot yet recruitingNCT07628894Phase 1
- Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid TumorsRecruitingNCT07628634Early Phase 1
- Dual-Target CSPG4/GD2 CAR-NK Cells for Advanced MelanomaRecruitingNCT07627698Phase 1/2
- A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic InformationRecruitingNCT07621614Phase 2
- PHOENIX-ECP- Extracorporeal Photopheresis for Immune-related Colitis and/or Hepatitis in Advanced Melanoma With Inadequate Response to Steroid ExposureNot yet recruitingNCT07619898Phase 2
- Comparing Intravenous or Intradermal Administration of Anti-CTLA-4 in Combination With Anti-PD1 Treatment in Patients With MelanomaNot yet recruitingNCT07615881Phase 1/2
- A First-in-Human Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of KUP-101A in Patients With Selected Advanced Solid TumorsRecruitingNCT07600476Phase 1
- Efficacy and Safety of Neoadjuvant Cadonilimab Plus High-Dose Recombinant Human Interferon α1b in Stage III/IV Melanoma.RecruitingNCT07586904Early Phase 1
- Exploratory Study With Parallel Controls on the Safety and Efficacy of Neoadjuvant Low Branched-Chain Amino Acid Diet in Combination With Anti-PD-1 Monoclonal Antibody for Stage III MelanomaRecruitingNCT07586891Not applicable
- Liquid Biopsy Multi-Omics and Biomarker Development in MelanomaRecruitingNCT07584291
- Pharmacokinetics, Safety, and Immunogenicity of Bmab1800 and Keytruda® as Adjuvant Monotherapy in Patients With MelanomaRecruitingNCT07581509Phase 1
- Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO TrialNot yet recruitingNCT07576725Phase 2
- MELCHRONO: A Prospective Randomized Study Investigating Chrono-immunotherapy for Advanced Melanoma.RecruitingNCT07574047Phase 2
- The Efficacy and Safety of PRTX007-003 Combined With Pembrolizumab in Resectable Stage III MelanomaRecruitingNCT07565285Phase 2
- Physical Activity Directly Before Immunotherapy (Nivolumab and Ipilimumab) in MelanomaRecruitingNCT07564570Not applicable
- Sun Exposure and Activities After Skin Cancer: Optimization of mHealth InterventionsRecruitingNCT07556380Not applicable
- Pilot Study of Bone Mineral Density Changes During Anti-PD-1 ImmunotherapyRecruitingNCT07555210Not applicable
- Superparamagnetic Iron Oxide for Sentinel Lymph Node Localization in Patients With Cutaneous Melanoma: MagMen-IINot yet recruitingNCT07552597Phase 3
- Sub-topic Four: Clinical Translation of Original Radioactive Drugs for Precision Diagnosis and Treatment of Gastrointestinal Tumors -Clinical Application Value of PET Imaging Targeting LRRC15 in Malignant TumorsRecruitingNCT07552467
- NO Re-excision MelanomA - NORMA 2RecruitingNCT07530887Phase 3
- Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanoma and Testicular Cancer, PerCS-YA TrialNot yet recruitingNCT07529080Not applicable
- Fianlimab&Cemiplimab as TotalNeoadj The (TNT) ForMelanomaNot yet recruitingNCT07527325Phase 2
- Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception (SHERLOCK)RecruitingNCT07524114
- Phase 1 Study of PF-08046033 in Advanced Solid TumorsRecruitingNCT07519655Phase 1
- A Study of HLX18 vs. OPDIVO® in Multiple Resected Solid TumorsRecruitingNCT07518043Phase 1
- Neoadjuvant SHR-1701 Plus Famitinib With Response-guided Adjuvant Therapy in Resectable Mucosal MelanomaNot yet recruitingNCT07517653Phase 2
- PROSECCO: A Phase 2, Single Arm, Neoadjuvant Study Evaluating Combination Cemiplimab, Fianlimab, And Ipilimumab In Patients With Surgically Resectable MelanomaNot yet recruitingNCT07511036Phase 2
- ctDNA-guided Addition of Ipilimumab to Patients Receiving Nivolumab and RelatlimabRecruitingNCT07504796Phase 2
- Neoadjuvant Pucotenlimab Combined With Lenvatinib and Temozolomide in Resectable Stage IIB/III Acral MelanomaNot yet recruitingNCT07501104Phase 2
- A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)RecruitingNCT07492680Phase 2
- Screening for Brain MetastasesNot yet recruitingNCT07492121Phase 2
- Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as Adjuvant Monotherapy in Participants With MelanomaRecruitingNCT07476326Phase 1
- Pharmacokinetic Similarity Study to Compare AVT32-DRL_PB With Keytruda® in Participants With Fully Resected MelanomaRecruitingNCT07475572Phase 1
- A Study of Biological, Genetic, and Constitutional Factors and Non-invasive Monitoring to Assess Personal Cancer RisksRecruitingNCT07469709
- A Study to Assess the Safety, and Tolerability of Nivolumab + Relatlimab Fixed-Dose Combination (FDC) In Unresectable or Metastatic Melanoma Participants In IndiaNot yet recruitingNCT07459543Phase 4
- Belvarafenib in Combination With Cobimetinib in Patients With Locally Advanced or Metastatic NRAS-Mutant MelanomaRecruitingNCT07449754Phase 2
- A Phase II Clinical Trial on Neo-adjuvant Pembrolizumab in Patients With pT3b-T4a/b cN0M0 Melanoma.RecruitingNCT07448831Phase 2
- Dose Ranging, Toxicity Seeking, Phase 1 Trial of Oncolytic Adenoviral Therapy for Melanoma Intracranial and Extracranial MetastasesNot yet recruitingNCT07444606Phase 1
- PD-L1 Targeting Peptide Probe for PET Imaging of Solid TumorNot yet recruitingNCT07442292
- Influence of a High-fiber Diet on the Microbiota and the Response to Immunotherapy in Patients Treated for Melanoma.Not yet recruitingNCT07437300
- Immunotherapy Efficacy and PD-L1 as a Predictive Biomarker in Metastatic Melanoma in SloveniaRecruitingNCT07422779Not applicable
- EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid TumorsRecruitingNCT07410676Phase 1/2
- Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid TumorsRecruitingNCT07410494Phase 1/2
- Efficacy of First-Line Immunotherapy in Metastatic Melanoma in Slovenia and Identification of Predictive BiomarkersRecruitingNCT07407166Not applicable
- HS-IT101 Injection Versus Chemotherapy in the Treatment of Advanced MelanomaNot yet recruitingNCT07406724Phase 2
- Navigation Intervention for Adolescent and Young Adult Cancer SurvivorsRecruitingNCT07406087Not applicable
- Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT StudyRecruitingNCT07405086Phase 4
- Electrochemotherapy-Induced Changes in Tumor Microenvironment in Cutaneous MelanomaRecruitingNCT07404605Not applicable
- INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP)RecruitingNCT07403630Not applicable